(Date:11/22/2009)...xposed prenatally to tobacco smoke and during chil...HD, according to research done at Cincinnati Child...ates that up to 35 percent of ADHD cases in childr...y eliminating both of these environmental exposure...n , "Tobacco and lead exposure each have their ...
(Date:11/22/2009)...ber 18, 2009 -- A butterfly,s proboscis looks like... but it works more like a paper towel, according t...s to borrow the tricks of this piece of insect ana...d inside of cells. , Kornev will present his wor...ican Physical Society,s (APS) Division of Fluid Dy...
(Date:11/20/2009)...t work on many scientific and technological fronti...provided support that totals nearly $4.3 million f...ors under the American Recovery and Reinvestment A...ed grants for investigation of solar phenomena. Ph... will enhance the capabilities of NJIT,s Big Bear ...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Possible Gene Regions for Schizophrenia Located 50567 1Possible Gene Regions for Schizophrenia Located 50567 2Oral Cancer Foundation Praised for Its Social Media Efforts 50564 1Oral Cancer Foundation Praised for Its Social Media Efforts 50564 2Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 1Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 2Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 3(Date:11/19/2009)...eople would like to be able to charge their cell p...ot too often. A recent discovery made by UC San Di...supercapacitors that could do just this. , In r...ers , Prabhakar Bandaru, a professor in the UCSD D... along with graduate student Mark Hoefer, have fou...
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-Fi... an innovator in biotechnology for diabetes therap...ulting services to food, supplement, biotechnology...closed the previously reported $6.3 million regist...f 2,760,870 shares of its common stock and warrant...
(Date:11/19/2009)..., MUNSTER, Germany, November 19 /PRNewswire/... filed on November 16th, 2009 Flibanserin in the,i...inesia in Parkinson,s,disease for orphan drug stat...(EMEA). Levodopa-induced dyskinesia is a complicat...n,s and a serious burden to some of those,affected...
(Date:11/19/2009)... InSound is honored by latest award... Newark, CA (PRWEB) November 16, 2009 -- P...;invisible” hearing aid from InSound Medical...Award in the Health category. &nb...igned to reside deep in the hearing canal for up t...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3... Monday, March 10, 2008 at 8:30am, NEW YORK, Marc...icals, Inc. (Nasdaq: KERX ), announced top-line r...f Sulonex (sulodexide) for the,treatment of diabet...ase 3,clinical trial failed to meet the primary ob...oportion of patients that achieve therapeutic succ...
... Q3 2008 -, TORONTO, March 10 /PRNewswire-FirstCa... or the "Company"), a medical technology company,d...oday announced the,randomization of the 100th pati...e, double-blind placebo-controlled randomized clin...acy of Complex Neural Pulse,(CNP(TM)) therapy for ...
...,Anesiva, Inc. (Nasdaq: ANSV ) today announced th...ug Application (sNDA) with the U.S. Food and Drug,...Zingo to treat the pain,associated with peripheral...) (lidocaine hydrochloride monohydrate) powder int...he FDA to provide local analgesia,prior to periphe...
Other Biology Technology:Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 4Fralex reaches 100th patient milestone in fibromyalgia study 2Fralex reaches 100th patient milestone in fibromyalgia study 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 4...ve, cost-effective solution to your TechMate Detec...ted quality into both our products and service cap...ies and antibodies that have been optimized to the...vely priced accessories that can be purchased indi...
...is buffer, PCR mix, DNA polymerase and universal c...This system can detect different types of Gram neg... Escherichia Coli, Klebsiella Pneumoniae, Bacillus...actiae, and etc. With the powerful Universal lysis...
pTRI-GAPDH-Human (316 bp protected fragment) from Ambion
...timized for serum-free growth of Ready-Plaque Sf9 ... Sf9 cultures routinely reach densities greater th...is medium is also recommended for plaque assays, w...nants develops faster than other formulations. Cel...
Biology Products: